Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Acetylcysteine (300mg) + Ambroxol (30mg)
Therapeutic Category
Pulmonary, Respiratory
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Mucipoly AM Tablet contains Acetylcysteine (300mg) and Ambroxol (30mg), a synergistic mucolytic and expectorant combination used to relieve cough and ease mucus clearance in respiratory conditions such as bronchitis, COPD, and asthma. It helps break down thick mucus, making breathing easier.
This product belongs to the respiratory care and general segment, making it a high-demand option for PCD pharma franchise, hospital supply, institutional tenders, and export markets.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Mucipoly A Tablet treats and prevents asthma and COPD symptoms by relaxing airway muscles for easier breathing.
Information regarding the use of Mucipoly A Tablet during breastfeeding is not available. Please consult your doctor.
Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.
Composition : Glycopyrrolate (25mcg) Respule
Composition : Formoterol (6mcg) + Budesonide (400mcg) Inhaler
Composition : Budesonide (0.5mg) Respule
Composition : Levosalbutamol (1.25mg) + Ipratropium (500mcg)
Composition : Terbutaline (1.25mg/5ml) + Acebrophylline (50mg/5ml) + Guaifenesin (50mg/5ml) Syrup
Composition : Acetylcysteine (600mg) effervescent
Composition : Salmeterol (25mcg) + Fluticasone Propionate (250mcg)
Composition : Acebrophylline (100mg) Capsule
Composition : Xylometazoline (0.1% w/v)
Composition : Acebrophylline (200mg) tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This combination tablet has strong demand in the respiratory segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on cough, mucus clearance, and lung care portfolios.
Medical distributors and agencies can benefit from consistent demand for mucolytic and respiratory therapy used in chronic bronchitis, COPD, asthma with thick mucus, chest congestion, and respiratory tract infections. Ambroxol helps loosen and expel mucus, while N-Acetylcysteine further breaks down mucus and supports antioxidant action, strengthening a strong respiratory care product portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for this combination tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong seasonal respiratory demand, chronic COPD prescription usage, hospital and general physician acceptance, reliable supply chain support, and good margins when partnering for this respiratory combination product.
Medical distributors, stockists, and wholesalers interested in Ambroxol + N-Acetylcysteine Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.